• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-苯胺基喹唑啉类蛋白激酶抑制剂的结合模式:与细胞周期蛋白依赖性激酶2和p38激酶结合的4-苯胺基喹唑啉的X射线晶体学研究

Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase.

作者信息

Shewchuk L, Hassell A, Wisely B, Rocque W, Holmes W, Veal J, Kuyper L F

机构信息

Glaxo Wellcome Inc., Five Moore Drive, Research Triangle Park, North Carolina 27709, USA.

出版信息

J Med Chem. 2000 Jan 13;43(1):133-8. doi: 10.1021/jm990401t.

DOI:10.1021/jm990401t
PMID:10633045
Abstract

4-Anilinoquinazolines represent an important class of protein kinase inhibitor. Modes of binding for two members of this inhibitor class were determined by X-ray crystallographic analysis of one inhibitor (4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline) in complex with cyclin-dependent kinase 2 (CDK2) and the other (4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline) in complex with p38 kinase. In both inhibitor/kinase structures, the 4-anilinoquinazoline was bound in the ATP site with the quinazoline ring system oriented along the peptide strand that links the two domains of the protein and with the anilino substituent projecting into a hydrophobic pocket within the protein interior. In each case, the nitrogen at position-1 of the quinazoline accepted a hydrogen bond from a backbone NH (CDK2, Leu-83; p38, Met-109) of the domain connector strand, and aromatic hydrogen atoms at C2 and C8 interacted with backbone carbonyl oxygen atoms of the peptide strand. The anilino group of the CDK2-bound compound was essentially coplanar with the quinazoline ring system and occupied a pocket between Lys-33 and Phe-80. For the p38-bound inhibitor, the anilino group was angled out of plane and was positioned between Lys-53 and Thr-106 in a manner similar to that observed for the aryl substituent of the pyridinylimidazole class of inhibitor.

摘要

4-苯胺基喹唑啉是一类重要的蛋白激酶抑制剂。通过对一种抑制剂(4-[3-羟基苯胺基]-6,7-二甲氧基喹唑啉)与细胞周期蛋白依赖性激酶2(CDK2)形成的复合物以及另一种抑制剂(4-[3-甲硫基苯胺基]-6,7-二甲氧基喹唑啉)与p38激酶形成的复合物进行X射线晶体学分析,确定了该抑制剂类别的两个成员的结合模式。在这两种抑制剂/激酶结构中,4-苯胺基喹唑啉均结合在ATP位点,喹唑啉环系统沿着连接蛋白质两个结构域的肽链定向,苯胺基取代基伸向蛋白质内部的一个疏水口袋。在每种情况下,喹唑啉1位的氮接受来自结构域连接链主链NH(CDK2中的Leu-83;p38中的Met-109)的氢键,C2和C8处的芳族氢原子与肽链的主链羰基氧原子相互作用。与CDK2结合的化合物的苯胺基与喹唑啉环系统基本共面,占据Lys-33和Phe-80之间的一个口袋。对于与p38结合的抑制剂,苯胺基与平面成一定角度,以类似于吡啶基咪唑类抑制剂的芳基取代基的方式位于Lys-53和Thr-106之间。

相似文献

1
Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase.4-苯胺基喹唑啉类蛋白激酶抑制剂的结合模式:与细胞周期蛋白依赖性激酶2和p38激酶结合的4-苯胺基喹唑啉的X射线晶体学研究
J Med Chem. 2000 Jan 13;43(1):133-8. doi: 10.1021/jm990401t.
2
Alternative binding modes of an inhibitor to two different kinases.一种抑制剂与两种不同激酶的交替结合模式。
Eur J Biochem. 2003 Aug;270(15):3174-81. doi: 10.1046/j.1432-1033.2003.03697.x.
3
Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine.嘌呤类似物对细胞周期蛋白依赖性激酶的抑制作用:人细胞周期蛋白依赖性激酶2与罗斯考维汀复合物的晶体结构
Eur J Biochem. 1997 Jan 15;243(1-2):518-26. doi: 10.1111/j.1432-1033.1997.0518a.x.
4
Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.与细胞周期蛋白A-Cdk2复合物结合的p27Kip1细胞周期蛋白依赖性激酶抑制剂的晶体结构。
Nature. 1996 Jul 25;382(6589):325-31. doi: 10.1038/382325a0.
5
Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine.配体识别的多种模式:细胞周期蛋白依赖性蛋白激酶2与ATP及两种抑制剂(olomoucine和异戊烯腺嘌呤)复合物的晶体结构
Proteins. 1995 Aug;22(4):378-91. doi: 10.1002/prot.340220408.
6
Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate.抑制剂与活性和非活性CDK2的结合:CDK2-细胞周期蛋白A/靛玉红-5-磺酸盐的晶体结构
Structure. 2001 May 9;9(5):389-97. doi: 10.1016/s0969-2126(01)00598-6.
7
X-ray crystallographic studies of CDK2, a basis for cyclin-dependent kinase inhibitor design in anti-cancer drug research.细胞周期蛋白依赖性激酶2的X射线晶体学研究,抗癌药物研究中细胞周期蛋白依赖性激酶抑制剂设计的基础。
Curr Med Chem Anticancer Agents. 2003 Jan;3(1):15-23. doi: 10.2174/1568011033353515.
8
Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.与磷酸化CDK2/细胞周期蛋白A结合的募集肽的特异性决定因素
Biochemistry. 2002 Dec 31;41(52):15625-34. doi: 10.1021/bi0268910.
9
Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.一种细胞周期激酶——人类细胞周期蛋白依赖性激酶2(CDK2)的黄酮类抑制剂的特异性和效力的结构基础。
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2735-40. doi: 10.1073/pnas.93.7.2735.
10
An analysis of the binding modes of ATP-competitive CDK2 inhibitors as revealed by X-ray structures of protein-inhibitor complexes.通过蛋白质-抑制剂复合物的X射线结构揭示的ATP竞争性CDK2抑制剂的结合模式分析。
Curr Med Chem Anticancer Agents. 2005 Sep;5(5):561-73. doi: 10.2174/1568011054866928.

引用本文的文献

1
In Silico Analysis of Mechanisms of Maribavir-Induced Inhibition and Drug Resistance Mutations in pUL97 Kinase Structural Prediction with AlphaFold2.利用AlphaFold2对马里巴韦诱导的pUL97激酶抑制机制和耐药性突变进行计算机模拟分析及结构预测
Viruses. 2025 Jul 2;17(7):941. doi: 10.3390/v17070941.
2
Design, synthesis, and studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects.新型喹唑啉酮标记的噻吩、噻吩并嘧啶和噻吩并吡啶支架作为具有潜在p38α丝裂原活化蛋白激酶抑制作用的抗增殖剂的设计、合成及研究
RSC Adv. 2025 Jan 16;15(2):1407-1424. doi: 10.1039/d4ra06744d. eCollection 2025 Jan 9.
3
GSK3179106 ameliorates lipopolysaccharide-induced inflammation and acute lung injury by targeting P38 MAPK.
GSK3179106 通过靶向 P38 MAPK 改善脂多糖诱导的炎症和急性肺损伤。
Respir Res. 2024 Oct 28;25(1):388. doi: 10.1186/s12931-024-03012-9.
4
Novel curcumin-based analogues as potential VEGFR2 inhibitors with promising metallic loading nanoparticles: synthesis, biological evaluation, and molecular modelling investigation.新型姜黄素类类似物作为具有前景的载金属纳米颗粒的潜在VEGFR2抑制剂:合成、生物学评价及分子模拟研究
RSC Med Chem. 2024 Sep 27;15(12):4039-67. doi: 10.1039/d4md00574k.
5
A comprehensive exploration of the druggable conformational space of protein kinases using AI-predicted structures.利用人工智能预测结构全面探索蛋白激酶的可成药性构象空间。
PLoS Comput Biol. 2024 Jul 24;20(7):e1012302. doi: 10.1371/journal.pcbi.1012302. eCollection 2024 Jul.
6
Preventing lipophilic aggregation in cosolvent molecular dynamics simulations with hydrophobic probes using Plumed Automatic Restraining Tool (PART).使用Plumed自动约束工具(PART)在含共溶剂的分子动力学模拟中,通过疏水探针防止亲脂性聚集。
J Cheminform. 2024 Feb 27;16(1):23. doi: 10.1186/s13321-024-00819-y.
7
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021-Present).近年来用于癌症治疗的基于喹唑啉的蛋白激酶抑制剂的结构优化进展(2021 年至今)。
Molecules. 2024 Feb 16;29(4):875. doi: 10.3390/molecules29040875.
8
Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer.硝呋齐特通过双重抑制三阴性乳腺癌中的STAT3和CDK2来增强帕博西尼诱导的衰老的抗癌疗效。
Cell Death Discov. 2023 Sep 26;9(1):355. doi: 10.1038/s41420-023-01658-w.
9
Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges.小分子抑制剂治疗肝细胞癌:进展与挑战。
Molecules. 2022 Aug 28;27(17):5537. doi: 10.3390/molecules27175537.
10
Characterization of Promising Cytotoxic Metabolites from Hemsl.: Computational Prediction and In Vitro Testing.来自血水草的有前景的细胞毒性代谢产物的表征:计算预测与体外测试
Plants (Basel). 2022 Mar 26;11(7):888. doi: 10.3390/plants11070888.